[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352956-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352956-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","genetic-and-genomic-approaches-to-explore-roles-for-the-conserved-3-5-exoribonuclease-exosc10-in-normal-and-malignant-cells","Genetic and genomic approaches to explore roles for the conserved 3′-5′ exoribonuclease EXOSC10 in normal and malignant cells","","EXOSC10 is a conserved nuclear 3′-5′ exoribonuclease that supports ribosomal RNA processing and degrades coding and noncoding transcripts as part of the nuclear RNA exosome, coordinated by cofactors. The protein undergoes posttranslational modifications and shuttles between the nucleolus and nucleus during oxygen deprivation via sumoylation. EXOSC10 is clinically relevant because 5-fluorouracil suppresses its activity and elevated expression in selected somatic tumors correlates with patient survival, prompting functional and genomics-based evaluation in normal versus malignant tissues.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/genetic-and-genomic-approaches-to-explore-roles-for-the-conserved-3-5-exoribonuclease-exosc10-in-normal-and-malignant-cells/352956/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/genetic-and-genomic-approaches-to-explore-roles-for-the-conserved-3-5-exoribonuclease-exosc10-in-normal-and-malignant-cells/352956.png","ImageObject",300,407,{"name":42,"@type":43},"Terk","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does EXOSC10 play in RNA metabolism?","Question",{"text":63,"@type":64},"EXOSC10 is a conserved 3′-5′ exoribonuclease that processes ribosomal RNAs and degrades both coding and noncoding transcripts as a catalytic subunit of the nuclear RNA exosome with cofactors.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is EXOSC10 regulated under oxygen deprivation?",{"text":68,"@type":64},"EXOSC10 shuttles between the nucleolus and nucleus in response to oxygen deprivation, involving sumoylation as part of its regulatory process.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is EXOSC10 considered medically important in cancer?",{"text":72,"@type":64},"Its activity is inhibited by the anticancer drug 5-fluorouracil, and high EXOSC10 expression in certain somatic tumors is associated with patient survival, supporting its evaluation as a prognostic biomarker.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352956,1790197310,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Genetic and genomic approaches to explore roles for the conserved 3′-5′ exoribonuclease EXOSC10 in normal and malignant cells  \nRADHIKA SAIN,1 JULIAN PRIMIG,2 and MICHAEL PRIMIG1  \n1Université de Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail)-UMR_S 1085, Rennes F-35042, France 2Faculté des Sciences et Ingénierie, Sorbonne Université, Paris F-75005, France  \nABSTRACT  \nEXOSC10 is a conserved 3′-5′ exoribonuclease involved in processing ribosomal RNAs and degrading coding and noncoding transcripts as a catalytic subunit of the nuclear RNA exosome and in cooperation with cofactors. The protein is posttranslationally modified and shuttles between the nucleolus and the nucleus in response to oxygen deprivation in a process that involves sumoylation. EXOSC10 is of medical interest because its activity is inhibited by the anticancer drug 5-fluorouracil, which interferes with DNA replication and RNA-dependent processes. Moreover, high expression of EXOSC10 in certain somatic tumors is associated with patient survival. We discuss global and tissue-specific deletion experiments in the mouse, assess the protein’s clinical relevance as a prognostic cancer biomarker in the context of human genomics data for normal versus malignant tissues, and explore EXOSC10’s transcriptional regulatory network.  \nKeywords: Rrp6; EXOSC10; RNA exosome; prognostic cancer biomarker; cancer  \nINTRODUCTION  \nRrp6, the budding yeast ortholog of mammalian EXOSC10, was initially reported to be a nonessential 3′ - 5′ exoribonuclease involved in ribosomal RNA processing, and later found to be involved in degrading and processing aberrant mRNAs and a wide variety of noncoding transcripts (Briggs et al. 1998; Neil et al. 2009; Xu et al. 2009; Gudipati et al. 2012) . The enzyme can act alone or in association with regulatory proteins, but it is thought to predominantly function as a catalytic subunit of the highly conserved nuclear RNA exosome; for review, see Stuparevic et al. (2021) . The human protein includes an N-terminal protein interaction domain (PMC2NT), an internal catalytic domain comprising two elements (EXO1 and HRDC), and an unstructured C-terminal region (Fig. 1A) . EXOSC10 is a hub protein that physically interacts with several core subunits and cofactors of the nuclear RNA exosome (Fig. 1B), associates with numerous proteins in multimeric complexes, and undergoes a variety of posttranslational modifications (PTMs), such as phosphorylation of serines, threonines, and tyrosines, and methylation, acetylation, sumoylation, and ubiquitination  \n[Corresponding author: michael.primig@inserm.fr](Corresponding author: michael.primig@inserm.fr)  \nArticle is online at [http://www.rnajournal.org/cgi/doi/10.1261/rna](http://www.rnajournal.org/cgi/doi/10.1261/rna)[.080981.126. Freely available online through the](.080981.126. Freely available online through the RNA Open Access)[ RNA](.080981.126. Freely available online through the RNA Open Access)[ Open Access](.080981.126. Freely available online through the RNA Open Access)[ ](.080981.126. Freely available online through the RNA Open Access)[option.](option.)  \nof lysine residues; for review, see Stuparevic et al. (2021)(Fig. 1C) .  \nHuman EXOSC10 is clinically relevant from several perspectives. First, it is among several RNA exosome subunits that are targeted by auto-antibodies in the polymyositis/ scleroderma overlap syndrome (hence its initial name PM/Scl-100 for polymyositis/scleroderma autoantigen 100 kD) (Bluthner and Bautz 1992; Ge et al. 1992; Staalsand Pruijn 2011) . Second, its enzymatic activity is inhibited by the widely used anticancer drug 5-fluorouracil (5-FU)(Kammler et al. 2008; Silverstein et al. 2011) . Third, EXOSC10 was reported to be a potential prognostic liver cancer biomarker (Meng et al. 2023) .  \nMouse gene deletion models are a major tool for functional studies of conserved mammalian genes potentially important for human development and diseas","cbCaiji2V7z32k0H","https://ap.wps.com/l/cbCaiji2V7z32k0H","pdf",34230140,13,"English","# Abstract\n# Introduction\n## EXOSC10 function and molecular features\n## Clinical relevance and therapeutic inhibition\n## Mouse gene deletion models and experimental design","[{\"question\":\"What role does EXOSC10 play in RNA metabolism?\",\"answer\":\"EXOSC10 is a conserved 3′-5′ exoribonuclease that processes ribosomal RNAs and degrades both coding and noncoding transcripts as a catalytic subunit of the nuclear RNA exosome with cofactors.\"},{\"question\":\"How is EXOSC10 regulated under oxygen deprivation?\",\"answer\":\"EXOSC10 shuttles between the nucleolus and nucleus in response to oxygen deprivation, involving sumoylation as part of its regulatory process.\"},{\"question\":\"Why is EXOSC10 considered medically important in cancer?\",\"answer\":\"Its activity is inhibited by the anticancer drug 5-fluorouracil, and high EXOSC10 expression in certain somatic tumors is associated with patient survival, supporting its evaluation as a prognostic biomarker.\"}]","Genetic and genomic approaches to explore roles for the conserved 3′-5′ exoribonuclease EXOSC10 in normal and malignant cells | PDF",1790102315,33,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/577eca1968a1c0a1746125785e5619f4.webp",983,1272,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e1080dd1a338fec9ccb2308994e77a8.webp",982,1270,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f72ba76789ddce893e9643a8a3e4b00c.webp",981,1269,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8659803589095c2aafc3fe2efe0a5ce.webp",980,1268]